Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
about
MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-propertiesThe molecular classification of medulloblastoma: driving the next generation clinical trials.Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med.Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
P2860
Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Which clinical and biological ...... ing childhood medulloblastoma.
@ast
Which clinical and biological ...... ing childhood medulloblastoma.
@en
Which clinical and biological ...... ing childhood medulloblastoma.
@nl
type
label
Which clinical and biological ...... ing childhood medulloblastoma.
@ast
Which clinical and biological ...... ing childhood medulloblastoma.
@en
Which clinical and biological ...... ing childhood medulloblastoma.
@nl
prefLabel
Which clinical and biological ...... ing childhood medulloblastoma.
@ast
Which clinical and biological ...... ing childhood medulloblastoma.
@en
Which clinical and biological ...... ing childhood medulloblastoma.
@nl
P2093
P356
P1433
P1476
Which clinical and biological ...... ing childhood medulloblastoma.
@en
P2093
Grotzer MA
Hartmann W
Kortmann RD
Rutkowski S
Warmuth-Metz M
von Bueren AO
P304
P356
10.1055/S-2007-985843
P577
2007-11-01T00:00:00Z